Briefly. . .

Biodel is raising $30 million via a public sale of stock, with the Danbury-based company developing an emergency treatment for a diabetic condition. Biodel is selling 32.6 million shares at 92 cents each, granting its underwriter William Blair 7 Co.



via Danbury Newswire http://ift.tt/1NMKovg